Pfizer Declares Fourth-Quarter 2019 Dividend
24 Setembro 2019 - 11:19AM
Business Wire
Board of Directors approves quarterly cash
dividend to $0.36 per share
The Board of Directors of Pfizer Inc. today declared a 36-cent
fourth-quarter 2019 dividend on the company’s common stock, payable
December 2, 2019, to holders of the Common Stock of record at the
close of business on November 8, 2019. Pfizer maintained the
dividend from the third-quarter at 36 cents per share. The
fourth-quarter 2019 cash dividend will be the 324th consecutive
quarterly dividend paid by Pfizer.
Pfizer Inc.: Breakthroughs that change patients’
lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.pfizer.com. In addition, to
learn more, please visit us on www.pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190924005750/en/
Investors: Ryan Crowe (212) 733-8160
Media: Patricia Kelly (212) 733-3810
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Pfizer (NYSE:PFE)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024